Open AccessCorrection: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type
Author(s) -
Luca Schifanella,
Susan W. Barnett,
Massimiliano Bissa,
Veronica Galli,
Melvin N. Doster,
Monica Vaccari,
Georgia D. Tomaras,
Xiaoying Shen,
Sanjay Phogat,
Ranajit Pal,
David C. Montefiori,
Celia C. LaBranche,
Mangala Rao,
Hung V. Trinh,
Robyn Washington-Parks,
Namal P. M. Liyanage,
Giacomo Gorini,
Dallas R. Brown,
Frank Liang,
Karin Loré,
David Venzon,
William Magnanelli,
Michelle Metrinko,
Josh Kramer,
Matthew W. Breed,
Galit Alter,
Ruth M. Ruprecht,
Genoveffa Franchini
Publication year - 2020
Publication title -
plos pathogens
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.719
H-Index - 206
eISSN - 1553-7374
pISSN - 1553-7366
DOI - 10.1371/journal.ppat.1008531
Subject(s) - adjuvant , human immunodeficiency virus (hiv) , virology , neutralization , hiv vaccine , medicine , virus , immunology , biology , vaccine trial